Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Hoek, Jantien
23  Ergebnisse:
Personensuche X
?
1

Nephrotoxicity as a Dose-Limiting Factor in a High-Dose Cis..:

Hoek, Jantien ; Bloemendal, Karen ; Van der Velden, Lilly-Ann...
Cancers.  8 (2016)  2 - p. 21 , 2016
Link: https://doi.org/10.3390/..
 
?
2

Nephrotoxicity as a Dose-Limiting Factor in a High-Dose Cis..:

Hoek, Jantien ; Bloemendal, Karen M ; van der Velden, Lilly-Ann A...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4773744/.  , 2016
Link: http://www.ncbi.nlm.nih...
 
?
3

Nephrotoxicity as a Dose-Limiting Factor in a High-Dose Cis..:

Jantien Hoek ; Karen M. Bloemendal ; Lilly-Ann A. van der Velden...
http://www.mdpi.com/2072-6694/8/2/21.  , 2016
Link: https://doi.org/10.3390/..
 
?
4

Nephrotoxicity as a Dose-Limiting Factor in a High-Dose Cis..:

Jantien Hoek ; Karen Bloemendal ; Lilly-Ann Van der Velden...
https://dx.doi.org/10.3390/cancers8020021.  , 2016
Link: https://doi.org/10.3390/..
 
?
5

Empirical evidence of transmission over a school-household ..:

van Iersel, Senna C.J.L. ; Backer, Jantien A. ; van Gaalen, Rolina D....
Epidemics.  43 (2023)  - p. 100675 , 2023
Link: https://doi.org/10.1016/..
 
?
6

A scenario modelling analysis to anticipate the impact of C..:

Ainslie, Kylie E C ; Backer, Jantien A ; de Boer, Pieter T...
Eurosurveillance.  27 (2022)  44 - p. , 2022
Link: https://doi.org/10.2807/..
 
?
7

Vaccinating children against influenza: overall cost-effect..:

de Boer, Pieter T. ; Backer, Jantien A. ; van Hoek, Albert Jan.
BMC Medicine.  18 (2020)  1 - p. , 2020
Link: https://doi.org/10.1186/..
 
?
8

ALIFE2 study: low-molecular-weight heparin for women with r..:

de Jong, Paulien G ; Quenby, Siobhan ; Bloemenkamp, Kitty WM...
Trials.  16 (2015)  1 - p. , 2015
Link: https://doi.org/10.1186/..
 
?
9

The inSIGHT study: costs and effects of routine hysteroscop..:

Smit, Janine G ; Kasius, Jenneke C ; Eijkemans, Marinus JC...
BMC Women's Health.  12 (2012)  1 - p. , 2012
Link: https://doi.org/10.1186/..
 
?
10

A scenario modelling analysis to anticipate the impact of C..:

Ainslie, Kylie E C ; Backer, Jantien A ; de Boer, Pieter T...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9635025/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
11

Vaccine effectiveness against SARS-CoV-2 transmission to ho..:

de Gier, Brechje ; Andeweg, Stijn ; Backer, Jantien A...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8569927/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
12

ALIFE2 study: low-molecular-weight heparin for women with r..:

de Jong, Paulien G ; Quenby, Siobhan ; Bloemenkamp, Kitty...
http://www.trialsjournal.com/content/16/1/208.  , 2015
Link: http://www.trialsjournal..
 
?
13

ALIFE2 study:Low-molecular-weight heparin for women with re..:

de Jong, Paulien G ; Quenby, Siobhan ; Bloemenkamp, Kitty W. M...
https://research.rug.nl/en/publications/060d2433-8d89-4c27-a0e5-ee9f16bc3aec.  , 2015
Link: https://hdl.handle.net/1..
 
?
14

ALIFE2 study: low-molecular-weight heparin for women with r..:

de Jong, Paulien G ; Quenby, Siobhan ; Bloemenkamp, Kitty WM...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4453290/.  , 2015
Link: http://www.ncbi.nlm.nih...
 
?
15

ALIFE2 study : Low-molecular-weight heparin for women with ..:

de Jong, Paulien G ; Quenby, Siobhan ; Bloemenkamp, Kitty W M...
1745-6215.  , 2015
Link: https://dspace.library.u..
 
1-15